Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Pacira BioSciences Inc.

    NASDAQ: PCRX · Real-Time Price · USD
    25.19
    0.30 (1.21%)
    At close: Aug 19, 2025, 3:59 PM
    1.21%
    Bid 20
    Market Cap 1.13B
    Revenue (ttm) 705.85M
    Net Income (ttm) -127.46M
    EPS (ttm) -2.75
    PE Ratio (ttm) -9.16
    Forward PE 7.41
    Analyst Buy
    Ask 25.19
    Volume 567,700
    Avg. Volume (20D) 648,416
    Open 24.93
    Previous Close 24.89
    Day's Range 23.74 - 25.20
    52-Week Range 12.61 - 27.64
    Beta 0.48

    About PCRX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol PCRX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for PCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Pacira BioSciences Inc. is scheduled to release its earnings on Nov 5, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    4 months ago
    +14.67%
    Pacira BioSciences shares are trading higher after... Unlock content with Pro Subscription
    4 months ago
    -0.82%
    Pacira BioSciences shares are trading higher after the company announced settlement of litigation related to EXPAREL patents.
    news image

    1 week ago · seekingalpha.com

    Pacira BioSciences, Inc. (PCRX) Q2 2025 Earnings Call Transcript

    Pacira BioSciences, Inc. (NASDAQ:PCRX ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Brendan P. Teehan - Chief Commercial Officer Frank D.

    news image

    2 weeks ago · zacks.com

    Here's What Key Metrics Tell Us About Pacira (PCRX) Q2 Earnings

    While the top- and bottom-line numbers for Pacira (PCRX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to ...

    news image

    2 months ago · zacks.com

    Is the Options Market Predicting a Spike in Pacira BioSciences Stock?

    Investors need to pay close attention to PCRX stock based on the movements in the options market lately.

    news image

    2 months ago · accessnewswire.com

    Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the Company"...

    news image

    2 months ago · accessnewswire.com

    Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Reach Out

    NEW YORK CITY, NY / ACCESS Newswire / May 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the Company"...

    Add to Watchlist